Randal Chase

Molecular Templates, Inc. operates as a holding company that engages in the discovery and development of immunotoxins for the treatment of cancer and other serious diseases. These are capable of targeting validated therapeutic cell surface receptors but also non-traditional targets that cannot be therapeutically targeted by antibodies or small molecules. Its product pipeline consists of lead candidates for non-Hodgkin's lymphoma, multiple myeloma, and breast cancer. The company was founded by Jean Gariépy and Leigh Revers in 2009 and is headquartered in Georgetown, TX.

North American Vaccine, Inc. develops and sells vaccines for the prevention of infectious diseases. The company is based in Columbia, MD. The company was founded by Jeffrey G. Spragens. North American Vaccine was acquired by Baxter International, Inc. on June 27, 2000 for $250.67 million.

Bioject Medical Technologies, Inc. develops and manufactures needle-free injection therapy systems. Its products include Biojector 2000, Needle Free Injection System, ZetaJet, Drug Reconstitution System, and Needle-Free Vial Adapter. The company was founded in 1985 and is headquartered in Tigard, OR.

MédiMabs, Inc. operates as a specialized boutique for antibodies and provides researchers with licensed products. It offers antigen design and strategy, polyclonal antibody development, Cryostorage, vaccine development and antibody validation services. The company was founded by A. Claudio Cuello in 2006 and is headquartered in Montreal, Canada.

Bristol-Myers Squibb Canada Co. designs, develops and wholesales pharmaceutical products. The company is headquartered in Halifax, Canada.

QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada.

ConjuChem, Inc. is a biotechnology company that has developed the Drug Affinity Complex (DAC™) Technology, a platform enabling the rapid creation of improved, patentable drugs from existing small organic compounds or peptides.

Quadralogic Technologies, Inc. manufactures pharmaceutical and herbicide products.

Mirexus Biotechnologies, Inc. develops personal care products. The firm specializes in personal care and cosmetics, nutraceuticals and biomedical. The company was founded by John Dutcher, Anton Korenevski, Erzebet Papp-Szabo and Oleg Stukalov and is headquartered in Guelph, Canada.

Shire Biologics, Inc. is an American company that manufactures pharmaceutical medicines.

Tissue Regeneration Therapeutics, Inc. operates as a biotechnology company. It develops osteoscaf, a biodegradable and osteoconductive scaffold for use in healing tissue defects. The company is headquartered in Toronto, Canada.